MY ACCOUNT
FEATURED ARTICLES
Development and Theoretical Approach to an Adaptive Text Message Program to Promote Well-Being and Health Behaviors in Primary Care Patients
Patients increasingly want to use their mobile devices to obtain health content. Could utilization of adaptive text message programs that provide specific health messages based on patient input be an effective way to promote health? Read this informative article to find out more.
Happiness and Treatment Outcome in Resistant Depression
This commentary discusses the implications of a recent article by Chen et al that investigated whether a patient's happiness level during ketamine infusion can predict their eventual antidepressant response to it.
Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder: Results of a Pilot Study
In this study, 25 overweight or obese women with major depressive disorder received up to 24 weeks of open-label treatment with a combination of 32 mg per day of naltrexone sustained-release and 360 mg per day of bupropion sustained release, along with dietary and behavioral counseling.
RECENT CME ACTIVITIES
Early-Stage Alzheimer Primer: Pathophysiology, Diagnosis, and Assessment
What are the steps for diagnosing Alzheimer disease? Are you familiar with diagnostic criteria and assessment tools? In this webcast, walk through the process with an expert.
EXP. 05.01.2023
Disclosure of Alzheimer’s Disease and Dementia: Patient- and Care Partner-Centric Decision-Making and Communication
Disclosing a diagnosis of dementia can be one of the most challenging aspects of care for clinicians. Here, learn strategies for disclosing the diagnosis.
EXP. 03.01.2022
Talking with Patients and Care Partners About Treatment Goals and Challenges in Early-Stage AD
In this webcast about early-stage Alzheimer disease, Drs Burke and Apostolova highlight important conversations to have with patients and their care partners on topics such as diet, exercise, driving, and plans for the later stage of illness.
EXP. 05.01.2023
Advances in Diagnosis of Alzheimer Disease and Emerging Treatment Targets
Great strides in research on Alzheimer disease diagnostic biomarkers and treatment targets have taken place over the past 2 decades. Listen as Dr Goldfarb highlights exciting developments.
EXP. 05.01.2023
A Patient-Centered Approach to Opioid Use Disorders
Explore the neurobiological, psychological, psychosocial, and cultural determinants of opioid use disorder, and review approaches to integrated, culturally competent care.
EXP. 05.01.2023
RECENT ARTICLES
Electroconvulsive Therapy as a Treatment for Tardive Dyskinesia
ECT may be a successful treatment for some cases of tardive dyskinesia. In this review, the authors accumulate all the recent evidence for the efficacy of ECT in treating tardive dyskinesia and make recommendations following data analysis.
Major Depressive Disorder With Seasonal Pattern or Seasonal Affective Disorder: Diagnostic Issues With Good Response to Agomelatine
Here, read the case of a patient who met some criteria for depression with seasonal pattern and seasonal affective disorder, but not all, posing a diagnostic dilemma. Could agomelatine be a possible treatment option?
Psychiatry in Iraq: Challenges and Consequences
In this commentary, the authors discuss the challenges in Iraq with regard to mental health care, especially in the context of COVID-19.
Early-Stage Alzheimer Primer: Pathophysiology, Diagnosis, and Assessment
What are the steps for diagnosing Alzheimer disease? Are you familiar with diagnostic criteria and assessment tools? In this webcast, walk through the process with an expert.
